Diagnosis & Treatment of EoE

CE / CME

Sending Out an SOS for EoE: Raising Awareness Around Diagnosis, Treatment, and Transition of Care

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: February 17, 2023

Expiration: February 16, 2024

Gwen Cassidy
Gwen Cassidy, APN
Ikuo Hirano
Ikuo Hirano, MD

Pretest

Progress
1 2
Course Completed
Please answer the questions below.
1.

Which patient demographic is most commonly associated with EoE?

2.

Which age group is associated with the correct typical presenting symptoms of EoE?

3.

Which treatment for EoE has the highest histologic remission rate?

4.

In a Phase III part B study, dupilumab was found to have which of the following outcomes in patients with EoE when compared to placebo?

5.

Which of the following is a risk factor for eosinophilic esophagitis (EoE)?

6.

Which of the following is part of the diagnostic criteria for EoE?

7.

Which medication is FDA approved to treat EoE?

9.

In your practice, how often do you currently increase suspicion of EoE for a patient with a history of atopic disease?

10.

How often do you currently evaluate for adaptive behaviors that mask symptoms of dysphagia?

11.

How often do you currently consider using biologic therapy in patients with EoE?

12.

How often do you currently have joint visits with pediatric and adult providers to assist with transition of care?

13.

Which of the following components does a successful transition of care program from adolescence to adulthood have?